Sunday, July 22, 2018
News

Alembic Pharma gets tentative USFDA nod for Ticagrelor tablets

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Mumbai | Thursday, Jul 12 2018 IST
Pharma Major, Alembic Pharmaceuticals said that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abberivated New Drug Application(ANDA) Ticagrelor tablets 90 mg.

The tentatively approved Abbreviated New Drug Application (ANDA) is therapeutically equivalent to the reference listed drug product (RLD), Brilinta tablets of Astrazeneca Pharmaceuticals LP.

It is used to reduce the rate of cardiovascular death and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (MI).

Quoting IQVIA sales data, the company said, Ticagrelor tablets, 90 mg had an estimated market size of USD625 million for 12 months, ending December 2017.

The company said it now has a total of 75 ANDA approvals from the USFDA.

UNI JS NV SM SDR 1440

-- (UNI) -- C-1-DL0171-1435611.Xml

Watch News Videos

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
TRENDING TOPICS
 
 
 
CITY NEWS
MORE CITIES
INDIA WORLD ASIA
Start-up help farmers in sowing seed pro...
Gunfight starts in Kashmir...
Bollywood film 'Chintuji' on DD National...
Casio mini keyboards makes learning musi...
Global businesses turn to Oracle Blockch...
Terrorist killed in Kulgam belonged to L...
More...    
 
 Top Stories
Neil Armstrong's memorabilia to be ... 
Twitter CEO responds to NYT journal... 
South Africa taxi shooting kills 11... 
5 dead, thousands hit by monsoon ra... 
Drake turns into an ice cream man!... 
734 youngsters shortlisted for Khel... 
Happy 26th Selena Gomez!... 
Prince George looks adorable in 5th...